Literature DB >> 26387882

Meta-analysis for aggregated survival data with competing risks: a parametric approach using cumulative incidence functions.

Federico Bonofiglio1,2, Jan Beyersmann3, Martin Schumacher4, Michael Koller5, Guido Schwarzer4.   

Abstract

Meta-analysis of a survival endpoint is typically based on the pooling of hazard ratios (HRs). If competing risks occur, the HRs may lose translation into changes of survival probability. The cumulative incidence functions (CIFs), the expected proportion of cause-specific events over time, re-connect the cause-specific hazards (CSHs) to the probability of each event type. We use CIF ratios to measure treatment effect on each event type. To retrieve information on aggregated, typically poorly reported, competing risks data, we assume constant CSHs. Next, we develop methods to pool CIF ratios across studies. The procedure computes pooled HRs alongside and checks the influence of follow-up time on the analysis. We apply the method to a medical example, showing that follow-up duration is relevant both for pooled cause-specific HRs and CIF ratios. Moreover, if all-cause hazard and follow-up time are large enough, CIF ratios may reveal additional information about the effect of treatment on the cumulative probability of each event type. Finally, to improve the usefulness of such analysis, better reporting of competing risks data is needed.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  competing risks; cumulative incidence function; meta-analysis; parametric hazard function; randomized controlled trial

Mesh:

Year:  2015        PMID: 26387882     DOI: 10.1002/jrsm.1165

Source DB:  PubMed          Journal:  Res Synth Methods        ISSN: 1759-2879            Impact factor:   5.273


  1 in total

1.  Shared parameter model for competing risks and different data summaries in meta-analysis: Implications for common and rare outcomes.

Authors:  Howard Thom; José A López-López; Nicky J Welton
Journal:  Res Synth Methods       Date:  2019-08-22       Impact factor: 5.273

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.